Preclinical drug development is a fundamental step in bringing innovative therapies to patients. Maximizing the potency of these therapies requires detailed understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a broad range of assays designed to define the fate and effect of